Amanote Research
Register
Sign In
Zulassungserweiterung Für ALK-Tyrosinkinaseinhibitor Crizotinib
Im Focus Onkologie
doi 10.1007/s15015-016-2347-y
Full Text
Open PDF
Abstract
Available in
full text
Date
February 1, 2016
Authors
Unknown
Publisher
Springer Science and Business Media LLC